This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It is the world’s largest supplier of generic medicine, in terms of volume with a 20% market share. According to the Economic Survey 2023, India’s domestic pharmaceuticalmarket was estimated at $41 billion. The roots of India’s pharmaceutical capabilities lay deep within its rich history. Kallam Anji Reddy.
It owns more than 27 CGD licenses and has operations in 44+ cities in six states and one Union Territory giving it a diversified footprint. The Gujarat government company is one of the largest CGD players in the country with a licensed area of 1,75,700 sq. Pharmaceuticals & Drugs ₹29,150.57 ₹242.80 Promoter Holding 60.9%
Kelly Nilsson, CFP®, CDFA®, JD Kelly’s journey in finance began in 1992, and for the first 17 years of her career she worked for financialmarketing firms and insurance companies, during which time her clients were financial advisors. transgender male and female investors.
Company Overview Sun Pharmaceutical Industries Ltd. Over the last 40 years, it has become the largest pharma company in India and the fourth-largest speciality generic pharmaceutical company in the world with a market capitalisation of Rs 2,25,000 crore. Now we’ll race through financials of the the stock.
So that’s fundamentally different, and it makes it harder for us to become a profession that it is, I think for those self-governing bodies… Wright: Well, I guess the only caveat to medicine is when you get into pharmaceuticals. Grillo: Next question. Well, we’ve kind of covered this already.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content